Pharmacokinetics of oxytetracyline in sheep after various intravenous doses

Oksitetrasiklin'in farmakokinetigi 20 koyun üzerinde araştırıldı. Araştırmada koyunlara, 40, 80 ve 160 mg/kg'lık oksitetrasiklin, damardan enjekte edildi. Her örnek alımda, artan dozlarla birlikte, hayvanların hepsinde oksitetrasiklin konsantrasyonunun yükseldiği gözlendi. 40, 80 ve 160 mg/kg'lik damariçi ulaç uygulamasından sonra, oksitetrasiklinin plazma konsantrasyonlarındaki en yüksek değerleri sırasıyla 18.67 ± 0.09, 40.63 + 0.16 ve 86.51 ± 0.10 µg/ml oldu. Bu plazma konsantrasiyonları sırasıyla 10.88 ± 0.29, 5.87 ± 0.08 ve 7.35 ± 0.08 saatlik yarılanma süreleriyle azalmıştır. MRT değerlerine göre oksitetrasiklin 40, 80 ve 160 mg/kg'lık dozlardan sonra 11.23 ± 0.25, 5.78 ± 0.08 ve 6.73 ± 0.05 saat koyunlarda kalmıştır. Ilacın verilmesinden sonra Clt'nin 8.71 ± 0.08, 9.73 ± 0.06 ve 9.74 ± 0.03 ml/saat olduğu bulunmuştur. Bu çalışmada üç üstel dozdan sora Vd'nin 8.19 ± 0.2, 5.09 ± 0.16 ve 6.22 + 0.06 litre olduğu sonucuna varıldı. Böylece oksitetrasiklinin plazma konsantrasyonunun doza bağlı olduğu sonucuna varıldı.

Koyunlarda çeşitli damariçi dozlarından sonra aksitetrasiklin' in pharmakokinetiği

Pharmacokinetics of oxytetracycline were investigated in 20 sheep following intravenous injection of 40, 80 and 160 mg/kg doses. An increase in concentration of oxytetracycline was found with increasing dose at all the sampling times in each animal. The peak plasma concentration of oxytetracycline attained after intravenous administration of 40, 80 and 160 mg/kg of the drug was 18.67±0.09, 40.63±0.16 and 86.51±0.10 mg/ml, respectively. These plasma concentrations decreased with plasma half lives of 10.88 ± 0.29, 5.87 ± 0.08 and 7.35 ± 0.08 hours respectively. Oxytetracycyine resided, as indicated by MRT for 11.23±0.25, 5.78±0.08, 6.73±0.05 hours post dosing of 40, 80 and 160 mg/kg body weight of drug. After administration of the drug the Clt was observed to be 8.71±0.08, 9.73±0.06 and 9.74±0.03 ml/h. The Vd in the present study was concluded to be 8.19±0.2, 5.09±0.16 and 6.22±0.06 liters after three exponential doses. It was, therefore, concluded that the plasma concentration of oxytetracycline is dose relate d according to the present investigation

___

  • 1. Brander C. C. and Pugh D. M. Veterinary Applied Pharmacology and Therapeutics. 3rd edn. Bailliere Tindall, London, 1982, pp 366-377.
  • 2. Nouws J. F. M. and Vree T. B. Effect of injection sites on the bioavailability of oxytetracycline formulation in ruminant calves. Vet. Quarterly, 1983; 5(4): 165-170.
  • 3. Nawaz M. Factors affecting disposition kinetics of sulphadimidine in animals. Proc. 2nd Cong., Europe Assoc. Vet. Pharmacol. Toxicol., 1982., pp 193-194.
  • 4. Arret B., Diana P., Johnson, Kirschbaum A. J. Outlines of details of microbiological assay of antibiotics. 2nd Revision. J. Pharm. Sci. 1971; 660: 1689-1694.
  • 5. PKII (computer program), MS-DOS version 2.10., Borland Inc., UK., 1988.
  • 6. Akaike H. An information Criterion (AIC), Math. Sci., 1976; 14: 5-9.
  • 7. SPSS (computer program) MS-Windows version 6, SPSS Inc., USA., 1992.
  • 8. Meiger L. A., Ceyssens K. G., De-Jong W. T., De-Greve B. I. Three phases of elimination of oxytetracyclin in veal calves; the presence of an extended terminal elimination phase. J. Vet. Pharmacol. Ther. 1993; 16(2): 214-222.
  • 9. Elsheikh H. A., Osman I. A., Ali B. H. Comparative pharmacokinetics of ampicillin trihydrate, gentamicine sulphate and oxytetracycline hydrochloride in Nubian goats and desert sheep. J. Vet. Pharmacol. Ther. 1997; 20(4): 262-266.
  • 10. George L. A., Magonigle R., Weirs R. Comparison of two oxytetracycline formulations in the treatment of laboratory induced pasturellosis in pigs. Am. J. Vet. Res. 1983, 44(50): 915-918.
  • 11. Toutin, P. L., Raynaud J. P. Pharmacokinetics of oxytetracycline in young cattle: comparison of conventional vs long acting formulations. Am. J. Vet. Res. 1983, 44(7): 1230-1209.
  • 12. Oukessou M. Uccelli-Thomas V., Toutin P. L. Pharmacokinetics and local tolerance of a long acting oxytetracycline formulation in camel. Am. J. Vet. Res. 1992; 53(9): 1658-1662.
  • 13. Ziv G. Serum oxytetracycline concentration in cows and calves after intramuscular injection of conventional and two long acting oxytetracycline preparations. Refuah Veterinarith. 1982, 39(4): 154-160b
  • 14. Black W. D., Claxton J. Robinson G. A. Study of serum drug levels in calves following I/M administration of three tetracycline durg preparations. Canad. Vet. J. 1982, 23(10): 296-298.
  • 15. Verma K. J., Paul B. S. Pharmacokinetics and plasma protein binding (in-vitro) of oxytetracycline in buffalo (Babalus bubalis). Am. J. Vet. Res. 1983, 44(3): 497-499.